Low Prevalence of Rotavirus and High Prevalence of Norovirus in Hospital and Community Wastewater after Introduction of Rotavirus Vaccine in Nicaragua by Bucardo, Filemón et al.
Low Prevalence of Rotavirus and High Prevalence of
Norovirus in Hospital and Community Wastewater after
Introduction of Rotavirus Vaccine in Nicaragua
Filemo ´n Bucardo
1,2, Per-Eric Lindgren
3, Lennart Svensson
2, Johan Nordgren
2*
1Department of Microbiology, University of Leo ´n, Leo ´n, Nicaragua, 2Division of Molecular Virology, Department of Clinical and Experimental Medicine, Linko ¨ping
University, Linko ¨ping, Sweden, 3Division of Medical Microbiology, Department of Clinical and Experimental Medicine, Linko ¨ping University, Linko ¨ping, Sweden
Abstract
Rotavirus (RV) and norovirus (NoV) are major causes of pediatric diarrhea and are altogether associated with approximately
800,000 deaths in young children every year. In Nicaragua, national RV vaccination program using the pentavalent RV5
vaccine from Merck was implemented in October 2006. To determine whether RV vaccination decreased the overall number
of RV infections, we investigated the occurrence of RV and NoV in wastewater in the city of Leo ´n from July 2007 to July 2008
and compared these data with pre-vaccination data. The major finding was the low prevalence of RV compared to NoV in all
sampling points (11% vs 44%, p,0.05), and that RV concentration was lower as compared to NoV. RV was observed mainly
during the rainy season (July–September), and the majority of all RV detected (6/9) belonged to subgroup (SG) I. The partial
VP7-gene obtained from one RV positive sample was similar (99% nt identity) to a G6 VP7-gene of bovine origin and similar
to the corresponding gene of the vaccine strain (98%). Furthermore RV G-types 2 and 4 were found in the incoming
wastewater. NoV strains were detected throughout the year, of which a majority (20/21) were of genotype GII.4. We
conclude that the introduction of RV vaccination reduced the transmission of RV in the community in Nicaragua. However,
the burden of diarrhea in the country remains high, and the high prevalence of NoVs in hospital and municipal wastewater
is noteworthy. This study highlights the need for further assessment of NoV following RV vaccine introduction.
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Introduction
Rotavirus (RV) causes approximately 111 million episodes of
diarrhea and is associated with 527,000 deaths in young children
every year, predominantly from developing countries. Norovirus
(NoV) causes 900,000 clinical visits in industrialized countries and
up to 200,000 deaths in children from developing countries
[1,2,3]. Rotavirus is classified in serogroups (A–G), and based on
molecular analysis of VP6 encoding gene, group A RV are divided
in subgroups (SGI and SGII) [4,5]. After safety and efficacy data
evaluation of the two licensed RV vaccines (Rotarix and RotaTeq)
the World Health Organization (WHO) strongly recommended
the inclusion of RV vaccines in the Expanded Program of
Immunization (EPI) of vulnerable countries [6]. From October
2006, the RotaTeq vaccine from Merck (RV5) is administered to
all Nicaraguan children that are age-eligible.
RV and NoV typically infect the cell lining of the gastrointestinal
tract and are discharged in very large numbers in the feces of
symptomatic and asymptomatic infected persons (.1610
8 virus
particlespergrams offeces)[7,8,9].Severalreportsindicate thatboth
virusesare frequentlyfound inwater contaminatedwithhuman feces
and detection rates follow a temporal pattern [10,11,12,13,14]. Viral
concentrationof RV and NoV can range between 1610
4 and 2610
7
genome equivalents per liter (g.e l
21) of raw wastewater [12,15,16].
By measuring enteric viral levels and determining the corre-
sponding genotypes in wastewater samples, it is possible to indirectly
monitor the presence of these enteric agents in the community.
Previous studies have found a correlation between enteric viruses in
wastewaterandvirusescausingdiseaseinthecommunity[14,17,18].
Furthermore, these types of investigations enable a more complete
view of virus diversity at community level by also detecting viral
strains that give rise to mild or asymptomatic infections, which are
generally not observed at the clinical level [12,17].
In this study, our objective was to determine whether the
introduction of the RV5 vaccine in Nicaragua had reduced the
circulation of RV in the community, and if shedding of RV
vaccine strains had occurred into wastewater. Furthermore, we
wanted to determine the temporal circulation of NoV and RV
during one-year in Nicaragua after RV vaccination. This was
carried out by performing a follow-up study of these viruses in
sewage from the local hospital and the main wastewater treatment
plant (WWTP) in the city of Leo ´n after introduction of the
pentavalent RV vaccine (RV5) in the EPI in Nicaragua.
In this study RV and NoV prevalence in wastewater was
investigated in a country of Central America which has
implemented RV vaccination in its national immunization
schedule. This is also the first study to characterize enteric viruses
in wastewater in Central America.
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Site description
This study was carried out in the city of Leo ´n, located close to
the pacific cost of Nicaragua with an estimated population of
200,000 inhabitants. The climate is tropical; the rain season starts
in June and lasts until November, when the dry season starts.
Nicaragua was the first GAVI-eligible country to introduce
rotavirus vaccination in October 2006. The Merck RV5 vaccine
is provided to all Nicaraguan children that are age-eligible [19].
Description of the wastewater treatment plant (WWTP)
The wastewater treatment plant was designed for clarification
and sedimentation of wastewater. In the first step solids are
removed by filtration. In the second step, large basins hold
wastewater for a period of time, allowing soil sediments or other
materials suspended in water to settle at the bottom. The last step
is to discard the clarified water into the local river (Rio Chiquito).
This WWTP receives wastewater from approximately 70% of the
households of Leo ´n, neighborhoods along the river including the
historical center and the ‘‘Hospital Escuela Oscar Danilo Rosales’’
(HEODRA). During the dry and rainy seasons approximately
235 l/s and 336 l/s pass through the WWTP, respectively
(personal communication, Lic. Maria Jose ´ Diaz). The clarified
water discharged by the WWTP eventually reaches the Pacific
Ocean through an estuary located at the pacific coast (Las Pen ˜itas)
of Nicaragua.
Wastewater samples
From July 2007 to July 2008 a total of 84 wastewater samples
were collected from the inflow and outflow of the WWTP as well
as from the wastewater drainer of the hospital (HEODRA). All
necessary permits were obtained for the described field studies by
the Director of HEODRA and the responsible for water affairs
(ENACAL) in Leo ´n. Weekly sampling was carried out every
Thursday morning, from July to December 2007, to cover the
rainy season, which coincides with the yearly epidemic peak of
diarrhea after the RV vaccine introduction [20]. Monthly
sampling (n=1) was then carried out the second Thursday of
each month from February until July 2008. No samples were
collected in January 2008 due to logistic constrains. A grab sample
was collected from the sewage drainer of the hospital, where
wastewater can be collected before reaching the public system,
between 7 and 8 AM (high flow). Then, between 9 and 10 AM, the
same day 2 grab samples were collected from the inflow (before the
mechanical filter) and outflow of the WWTP, respectively. At each
site, 50 ml of sewage water was collected in sterile BD Falcon
TM
conical tubes (Becton, Dickinson and Company), and transported
at 4uC to the microbiology laboratory of UNAN-Leo ´n. Samples
were then frozen at 220uC and transported to Linko ¨ping
University, Sweden, for further analysis. Prior to sample collection,
temperature and pH were registered. To avoid carryover
contamination, tubes containing the samples were not opened
until ultracentrifugation.
Sample clarification and virus concentration
Before processing, samples were thawed overnight at 4uC, and
clarified by centrifugation at 3,5006g for 5 min at 4uC. A total of
38 ml of supernatant were transferred to a thin wall, Ultra-
Clear
TM ultracentrifugation tube (Beckman, 344058). Ultracentri-
fugation was carried out in the Beckman Coulter - Optima
TM L-
100XP preparative ultracentrifuge (Beckman Coulter, Inc, CA,
USA) using a SW 32 Ti Rotor at 164,000 g for 2 hours. A total of
37.5 ml of the supernatant was discarded by pipetting and the
pellet was re-suspended in 0.5 ml of supernatant and frozen at
220uC until viral RNA purification. Distilled water was used as
negative control in every round of centrifugation.
RNA extraction
Viral RNA was extracted from 140 ml of the diluted pellet,
following the manufacturer’s instructions using a QIAamp Viral
RNA Mini Kit (QIAGEN, Hilden, Germany). A total of 60 mlo f
viral RNA was collected and stored at 270uC until reverse
transcription (RT).
Reverse transcription
RT was essentially carried out as described previously [9,21].
Briefly, 28 ml of RNA was mixed with 50 pmol of random
hexadeoxynucleotides [pd(N)6] (GE Healthcare Bio-Sciences AB,
Uppsala, Sweden), denatured at 97uC for 5 min, and quickly
chilled on ice for 2 min, followed by addition of one RT-PCR
bead (GE Healthcare Bio-Sciences AB) and RNase-free water to a
final volume of 50 ml. The RT reaction was carried out for 30 min
at 42uC to synthesize the cDNA used for screening and
quantification of RV and NoV.
Detection and quantification of RV and NoV
RV was detected, subgrouped and quantified using a real-time
PCR assay [5]. The assay can subgroup RV strains based on
subgroup specific fluorogenic primers targeting the VP6-gene, and
semi-quantify using external plasmid standards.
NoV detection and quantification were performed with a real-
time PCR targeting the ORF1-ORF2 junction, as described by
Nordgren and co-workers [22]. This real-time PCR assay can
semi-quantify and distinguish between NoVs GI and GII [22].
Determination of NoV and RV concentrations and
reduction
By using a standard curve in each real-time PCR assay as
described elsewhere [5,22], the number of viral genomes per real-
time PCR reaction was determined, thus allowing us to estimate
the number of both NoV and RV particles per liter of wastewater.
The lowest detection level of NoV and RV in the real-time PCR
assay is theoretically 1 gene per PCR reaction which corresponds
to 2.5610
3 genome equivalents (g.e.) per liter (l
21)o fH 2O using
the methodology described in this paper. Furthermore, quantifi-
cation of concentrations lower than 2.5610
4 g.e. l
21 H2O (10
genes per PCR reaction) is less accurate due to less linearity of the
real-time PCR standard curve close to the detection limit. The
reduction of virus in the wastewater treatment plant was
determined as the log10 transformation of the quotient of amount
of virus before treatment, and the amount of virus after treatment.
Due to the limited detection of RV in wastewater, the reduction
was only determined for NoV. When NoV was below the
detection limit in the outgoing water, a hypothetical value of
1.25610
3 g.e. l
21 H2O (which corresponds to approximately half
of the detection limit) was given for measurement of average
reduction levels [12,23].
RV VP7 genotyping and sequencing
A PCR mix was prepared by mixing 2.5 ml of cDNA, 4 pmol of
each consensus primer (VP7-F and VP7-R) [24], 20.5 mlo f
RNase-free water and a PuReTaq Ready-To-Go PCR bead (GE
Healthcare Bio-Sciences AB). PCR was performed at 94uC for
2 min, followed by 35 cycles of 94uC for 1 min, 50uC for 1 min,
and 72uC for 1 min, with a final extension of 72uC for 7 min. The
VP7 PCR-product was stored at 220uC until VP7 genotyping. A
Rota-and Norovirus in Wastewater after Vaccination
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4 pmol of each G genotype-specific and consensus primers (G1,
G2, G3, G4, G8, G9 and VP7-R) [24], 23 ml of RNase-free water
and a PuReTaq Ready-To-Go PCR bead (GE Healthcare Bio-
Sciences AB). PCR was performed at 94uC for 4 min, followed by
30 cycles of 94uC for 1 min, 42uC for 2 min, and 72uC for 1 min,
with a final extension of 72uC for 7 min. The PCR products were
analyzed using 2% agarose gel and ethidium bromide staining,
VP7 genotypes were assigned as described elsewhere [24].
The VP7 gene from one sample, containing sufficient RV
concentration to enable an amplification of the VP7-gene, was
sequenced using BigDye chemistry at Macrogen Inc. (Seoul, South
Korea), with the primers VP7-F and VP7-R [24] as sequencing
primers.
PCR amplification and cloning of the NoV N-terminal and
shell (NS) region
PCR amplification of the NS region was performed using the
forward primer [22] and reverse primer [25] as described
elsewhere [9]. The NoV NS capsid fragment was cloned into
pJET1.2 vector and transformed into E.coli cells using CloneJet
TM
PCR Cloning and TransformAid
TM Bacterial Transformation kits
(Fermentas, St. Leon-Rot, Germany) according to the manufac-
turer’s instructions. Ten separate colonies from each transforma-
tion reaction were screened by PCR for the correct gene insert.
After overnight incubation of positive colonies, plasmid DNA was
extracted and purified using GeneJET
TM Plasmid Miniprep Kit
(Fermentas, St. Leon-Rot, Germany) according to the manufac-
turer’s instructions. Nucleotide sequencing was performed by
Macrogen Inc. (Seoul, South Korea), using the BigDye chemistry
with pJET1.2 forward and reverse sequencing primers.
Genotyping of NoV by sequence analysis of the NS
region
Sequence alignment of the Nicaraguan strains and reference
NoV genotypes representing known genotypes as well as GII.4
variants, was performed by using the ClustalW algorithm, version
2, at the European Bioinformatics Institute server (EMBL-EBI).
Phylogenetic analysis was performed using the MEGA 5.0
software package, and the tree was constructed using the
neighbor-joining and Kimura two parameter methods. Signifi-
cance of the relationship was obtained by bootstrap re-sampling
analysis (1,000 replications).
Nucleotide accession numbers
The nt sequences as used for phylogenetic analysis (nt position
5085 to 5366; Ref acc.no X86557) of the norovirus NS region
have been deposited in GenBank under accession numbers
JN102111–JN102131.
Statistical analysis
Statistical analysis was performed using SPSS software (version
19, SPSS, Chicago, IL). Differences in RV and NoV prevalence in
sewage water were determined by the use chi-square tests or
Fisher’s exact test. P-values of ,0.05 were considered statistically
significant.
Results
Low prevalence of RV and high prevalence of NoV in
hospital and community wastewater
All wastewater samples from July 2007 to July 2008 were tested
for RV and NoV using sensitive real time-PCR methods [5,22]
and the results demonstrated RV and NoV in 9 (11%) and 37
(44%) of the 84 sewage samples, respectively. Of the 9 RV-positive
samples, 7 were also positive for NoV. The prevalence of RV in
samples collected at the hospital wastewater, WWTP-inflow and
WWTP-outflow were 7% (2/28), 21% (6/28) and 4% (1/28),
respectively. In contrast, a higher NoV prevalence was observed at
all sampling points, with 46% (13/28) in the hospital water, 54%
(15/28) at the WWTP-inflow and 32% (9/28) at the WWTP-
outflow (p,0.05; for all sampling points) (Table 1).
Seasonality of RV and NoV in the wastewater samples
This epidemiological parameter was investigated in the samples
collected at the inflow of the WWTP, as they best represent the
Table 1. Temporal distribution of rotavirus and norovirus in wastewater samples post RV5 introduction in Leo ´n, Nicaragua, 2007–
2008.
Month of
Collection
No. of
samples No. of RV-positive/tested samples No. of NoV-positive/tested samples
Hospital Inflow WWTP Outflow WWTP Hospital Inflow WWTP Outflow WWTP
Jul 07 12 0/4 2/4 1/4 3/4 4/4 4/4
Aug 07 15 0/5 2/5 0/5 3/5 3/5 1/5
Sept 07 12 2/4 1/4 0/4 2/4 2/4 2/4
Oct 07 12 0/4 0/4 0/4 0/4 0/4 0/4
Nov 07 9 0/3 0/3 0/3 0/3 1/3 0/3
Dec 07 6 0/2 0/2 0/2 2/2 1/2 1/2
Feb 08 3 0/1 1/1 0/1 0/1 1/1 1/1
Mar 08 3 0/1 0/1 0/1 0/1 1/1 0/1
Apr 08 3 0/1 0/1 0/1 0/1 0/1 0/1
May 08 3 0/1 0/1 0/1 1/1 0/1 0/1
Jun 08 3 0/1 0/1 0/1 1/1 1/1 0/1
Jul 08 3 0/1 0/1 0/1 1/1 1/1 0/1
All months 84 2/28 (7.1%) 6/28 (21.4%) 1/28 (3.6%) 13/28 (46.4%) 15/28 (53.6%) 9/28 (32.1%)
doi:10.1371/journal.pone.0025962.t001
Rota-and Norovirus in Wastewater after Vaccination
PLoS ONE | www.plosone.org 3 October 2011 | Volume 6 | Issue 10 | e25962viruses circulating in the community. RV-positive samples were
observed in July (2/4), August (2/4) and September (1/4) of 2007,
and disappeared in the following months of surveillance, except in
February (1/1) of 2008 (Table 1). An interesting observation was
that RV seemed to circulate in the community a few weeks in July
and August before its appearance in the hospital sewage water in
September 2007 (Table 1). While RV circulated in very short time
frames, NoV circulated year around, and only in the months of
October of 2007 and April–May 2008 was it absent in wastewater
(Table 1). NoV seemed to exhibit two periods of high
concentration in incoming wastewater, during the rainy season
(July to September), and during the winter season (November to
March) while RV was mainly detected during the rainy season
(July to September 2007) (Table 1).
Higher concentrations of NoV compared to RV in hospital
and community wastewater samples
To investigate if RV and NoV quantities in the sewage were
related to frequency, time and place of collection, we measured
viral concentrations for NoV and RV in all sampling and time
points. The frequency of RVs was low as compared to NoVs,
which was also reflected in the quantification data (Fig. 1). The
concentration of NoV ranged between 1.3610
4 to 5.7610
6 g.e.
l
21 H2O. The highest concentration of NoV was found in hospital
sewage in September 2007 (2.6610
6 g.e. l
21 H2O) and in the
inflow to the WWTP in December 2007 (5.7610
6 g.e. l
21 H2O).
The concentration of RV ranged between 1.3610
4 and 4.0610
5
g.e. l
21 H2O. The highest concentrations of RV were found in the
inflow of the WWTP in September 2007 (2.6610
5 g.e. l
21 H2O)
and in hospital sewage in September 2007 (4.0610
5 g.e. l
21 H2O)
(Fig. 1). We furthermore measured the reduction level of NoV in
the WWTP at all time-points where NoV was detected in
incoming wastewater (n=15), and observed that NoVs were
reduced on average 1.1560.29SE log10 units in the treatment
process.
The majority of all RVs detected belonged to subgroup I
Of the 9 RV-positive samples, 6 (67%) belonged to SGI, and 3
(33%) belonged to SGII. All RV-positive samples found in the
hospital wastewater (n=2) belonged to subgroup SGI; and were
collected in September 2007. The two RV subgroups were not
simultaneously observed in any samples investigated. We
sequenced the VP7 gene of one SGI RV-positive (37-Sept07-
Hospital) which had relatively high viral load. This sample was
previously negative for the following G-types; G1, G2, G3, G4,
G9, G8 and G10, using the nested multiplex PCR assay (data not
shown). BLAST analysis of a short 165 nt segment of the VP7-
gene revealed high nucleotide homology (99%) to bovine G6
strains isolated in New Zealand (RotaBovG6-NZ), China (CHLY)
and India (B-85). Moreover, the nucleotide sequence was also
homologous (98% nt similarity) to the human-bovine reassortant
vaccine strain (P1 WC36WI79 [WI79-4]) (Fig. 2A).
We furthermore detected G2 and G4 VP7-specificities, as
determined by the nested multiplex PCR assay, in the inflow to the
WWTP in July (n=1) and September 2007 (n=1), respectively.
The VP6 subgroup determination in both samples revealed SGI
and SGII specificities, respectively.
The majority of NoVs belonged to genotype GII.4
Of the 37 NoV-positive samples, 28 (76%) were GII strains and
2 (5%) were GI strains, while both NoV genogroups were detected
in 7 (19%) of the samples. To study NoV diversity, NoV-positive
sewage samples with high viral load were selected for cloning and
nucleotide sequencing, and for a subset of these (n=5) collected in
July, September and December of 2007 we obtained clones. In
total 21 clones containing a segment (nt position 5085 to 5366) of
the NS region of NoV were sequenced, 20 (95%) of these were
highly homologous (99% nt similarity) to GII.4 NoV strains. One
NoV clone, observed in the inflow of wastewater in September
2007, was highly homologous (100% nt identity) to GII.3 NoV
isolated from children with community acquired diarrhea in
October 2007 in UK, and to a GII.3 NoV strain isolated from a 30
year old male from Kolkata, India in 2008 (Fig. 2B).
Discussion
In this study we investigated the prevalence of NoV and RV in
hospital and municipal wastewaters in order to understand the
transmission of these viruses at community and hospital level
following implementation of RV vaccination in Nicaragua.
The major novel finding was the low prevalence of RV, further
emphasized by the high prevalence of NoVs in both hospital and
municipal wastewater. Several studies have reported higher
frequencies of RV as compared to NoV in wastewater. Research
groups from China, Tunisia and Germany described detection
rates of RV ranging from 32% to 90% and NoV from 3% to 31%
[26,27,28]. In hospital wastewater, Prado and coworkers observed
RV in 95% and NoV GII in 28.5% of the samples collected
between 2005 and 2008 in Rio de Janeiro, Brazil. [29]. In the
current study mean RV prevalence in wastewater from different
sources was only 11%, whereas, it was 44% for NoV (p,0.05).
Moreover, in hospital wastewater, NoV was detected in 46.4%,
whereas RV was only detected in 7.1% of the samples. This
suggests a low frequency of severe hospital-requiring RV infections
in the community as recently reported [30]. Furthermore,
differences were not only observed in virus prevalence, but also
in virus concentration; in average RV concentrations were lower
as compared to NoV concentrations, both in hospital and in
community wastewater. These observations suggest a high NoV
transmission at population level in Leo ´n, Nicaragua, during the
time frame investigated, which is supported by the large burden of
diarrhea that still persists in Leo ´n after RV5 introduction [20].
Taken together, these observations strongly suggest that the
implementation of RV5 in the EPI reduced the transmission of
Figure 1. Concentrations of NoV and RV in different sampling
points. The horizontal lines represent geometric mean with 95%
confidence interval.
doi:10.1371/journal.pone.0025962.g001
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recent report further supports this suggestion indicating that the
RV immunization program in Leo ´n is effective in reducing
diarrhea episodes during the RV season [20]. In earlier studies
from Nicaragua, the dry months (February–April) are usually
associated with high rates of RV-induced diarrhea [21,31]. In this
study, however, most RVs were detected in wastewater during the
rainy season (July–September) indicating a shift in the epidemi-
ological pattern for RV. A similar shift has also been observed in a
study from United States, reporting a delay of 15 and 8 weeks in
the onset and peak of the RV season in 2007 and 2008
respectively, compared to the pre-vaccine periods 2000–2006
[32]. However, the differences in detection rates could also be
partially attributed to the study design. Sample collection was not
uniform throughout the year; samples were collected weekly at the
WWTP during the rainy season and until Christmas holidays
(July–December 2007), whereas samples were collected monthly
during the remainder of the study period.
The real-time PCR assays used for detection and quantification
of these viruses are based on the same chemistry and have similar
efficiencies [5,22]; therefore the difference in observed prevalence
should not be due to differences in the detection methods, neither
due to the concentration method, as ultracentrifugation has been
shown to be more efficient to recover RV from wastewater as
compared to ultrafiltration-adsorption-elution method [33].
The NoV concentrations in incoming wastewater for treatment
ranged from 1.3610
4 to 5.7610
6 g.e l
21 H2O. The NoVs were
reduced on average 1.1560.29SE log10 units in the WWTP of
Leo ´n, albeit with variations in reduction between different time
points. Furthermore, NoV was found in 32.1% of the outgoing
wastewater samples from the treatment plant, demonstrating high
transmission of NoV into the water environment even after the
treatment process, suggesting that a disinfection step is needed.
RV, however, was only detected in one outgoing wastewater
sample (3.6%) (Table 1). The low reduction of NoV in the WWTP
with subsequent high transmission into the environment is of
concern, due to the environmental stability of the virus and its
association with food and waterborne outbreaks [34,35].
We characterized RV and NoV by sequencing. The RV
concentration in wastewater was low, thus only one partial
sequence of the VP7 gene from a water sample where we detected
RV SGI-specificity with the real-time PCR assay, designated ‘‘37-
Sept07-Hospital’’, detected in hospital wastewater in September
2007 was obtained. The sequencing data demonstrated relatedness
with animal RVs, having a high nucleotide homology (99%) with
bovine strains detected in New Zealand, China and India
belonging to the G6 genotype, which is the most common
genotype found in calves elsewhere [36,37]. The ‘‘37-Sept07-
Hospital’’ sequence was also highly similar (98% nt homology)
with the human-bovine reassortant vaccine strain (P1 WC36WI79
Figure 2. Phylogenetic analysis of (A) a RV VP7-gene fragment
(165 bp, nt 637 to 801, ref acc.no. M12394) isolated from
sewage water collected at the local hospital of Leo ´n, Nicaragua
in September 2007. (B) Partial capsid NS region (282 bp; 5085 to
5366; ref acc.no. X86557) of NoV GII cDNA (n=21) isolated from sewage
water collected at the local hospital and the WWTP of Leo ´n, Nicaragua
in 2007. Both trees were constructed based on the Kimura two-
parameter and neighbor-joining methods by use of MEGA 5.0 software.
Bootstrap values are shown at the branch nodes (values of ,50% are
not shown). RV G4Nic181/05 and Sapporo virus GI/1 (ref. acc.
no. U65427) were used as outgroups, respectively. For Nicaraguan
strains isolated in this study, the number of the sample and clone is
given, followed by month of sample collection and site of collection
(HO: Hospital; WWTP: Wastewater Treatment Plant).
doi:10.1371/journal.pone.0025962.g002
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bovine origin [38]. However, the sample containing this bovine-
like RV strain was negative for the human G1, G2, G3, G4, G8,
G9 and G10 genotypes. The RV5 contains five human-bovine
reassortant strains, each with a different human VP7 (G1, G2, G3
or G4) or VP4 (P[8]) specificities that could be detected by RT-
PCR [39]. Virus excretion from children vaccinated with RV5 is
seldom reported [40], but can occur [41]. Since this sample was
isolated from the hospital wastewater, it is likely that it contains a
bovine-like RV from symptomatic children. Previously, a zoonotic
bovine RV strain with G8 specificity has been identified in a
diarrheic child during the monitoring of RV vaccine program in
Nicaragua in 2008 [42]. However, it cannot be ruled out or
confirmed that it was the vaccine strain which was detected in this
study, as more sequence data will be needed to elucidate this.
The majority (6/9) of RV-positive wastewater samples were of
SGI specificity, which is generally associated with human rotavirus
G2P[4] [4]. In the current study RV G2 was observed in one
wastewater sample, therefore we can speculate but not prove that
RV of G2P[4] specificity were circulating in Leo ´n during the time
frame investigated, but at very low frequency. This speculation is
strengthened by the fact that G2P[4] represented 88% of the RVs
identified in a hospital surveillance carried out in the capital city of
Nicaragua (Managua)between2007 and 2008 [43]. Thecirculation
of RV with P-types not included in the RV5 vaccine, such as P[4]
and P[6] might be an expected phenomena after national vaccine
implementation [43]. Previous studies from Nicaragua investigating
RV genotypes in 2001–2003, 2005 and 2006 [21,31,44], found
G2P[4] to be the dominating genotype in 2001, but since then
circulating at low frequencies. The observed high prevalence of
G2P[4] in Nicaragua 2007 and 2008 is likely due to naturally
occurring shifts, rather than selection by RV5 introduction, since a
very similar re-emergence of G2P[4] strains has been observed in
otherSouth- andCentral-Americancountries,wherenonationwide
vaccine has yet been introduced [45].
Moreover, it cannot be ruled out that some of the SGI RV
strains observed in wastewater were derived from animals, since
SGI RVs are more common in animals than in humans [4,46]. In
the city of Leo ´n, cattle and other domesticated animals are
common and the sewage system also collects dump from these
animals.
We observed a low frequency of GI NoVs (5%), and the few
samples positive for this genogroup had low concentrations, which
made it difficult to further characterize. There are reports from
Japan, France and Sweden showing higher frequency of GI NoVs
during some months, indicating a high transmission of these
viruses in the community [12,47,48]. NoV GI has often been
associated with food and waterborne outbreaks [49,50,51]. In this
study, NoV GII was the most prevalent genogroup throughout the
time-period investigated. Samples containing high NoV GII
concentrations (.1610
5 g.e l
21 H2O) from different sampling
and time points were selected for cloning and sequencing. We
characterized NoV GII strains from hospital sewage in July,
September and December 2007, as well as the inflow to the
WWTP in September and December 2007. All NoV clones from
the hospital wastewater were genotyped as GII.4 (Fig. 2B). NoV
GII.4 has previously been the most common NoV strains detected
in pediatric diarrhea in Nicaragua, and are ubiquitous worldwide
[9,52]. As described elsewhere [52], the GII.4 Hunter strain was
globally replaced by GII.4 2006a/b in early 2006. However, the
short segment of the NS region we sequenced in this study is not
sufficient to accurately determine the exact GII.4 variant observed.
The fact that all clones from the hospital wastewater were
genotyped as NoV GII.4 reflects the importance of this genotype
in NoV-associated diarrhea in Nicaragua. We found one NoV
GII.3 strain in September 2007 in the inflow of the WWTP. The
fact that a NoV GII.3 strain was only observed in the municipal
wastewater and not in the hospital wastewater might suggest that
NoV GII.3 was circulating at community level causing less severe
or asymptomatic infections.
The detection of NoV GII.4 strains in July, September and
December demonstrates a stable circulation of NoV GII.4 in
Nicaragua after RV vaccine introduction. Usually, NoV GII.4
variants are associated with seasonal epidemics and a given variant
predominate for a period of time until replaced by a new variant
[53]. The presence of one particular NoV variant throughout the
year in the current study is interesting, as higher NoV diversity
have been observed in water samples from other studies [47,54].
However, the differences could be attributed to temporal
fluctuations of NoV strains in the community; no clinical data
regarding NoV genotypes is available for the same time-period
investigated. In an earlier clinical report from Nicaragua, a high
diversity of NoV genotypes was found in April to June in children
with diarrhea, whereafter GII.4 strains dominated [9]. Unfortu-
nately, in the current study no wastewater samples collected
between April and June had sufficient viral concentration to
enable NoV genotyping. Whether a change of dynamics of NoV
circulation occurs due to the introduction of RV vaccine remains
to be elucidated
To conclude, this paper demonstrated low prevalence of RV
and high prevalence of NoV in wastewater in Leo ´n Nicaragua
during the post RV vaccination period. The results suggest that
implementation of the RV5 vaccine has reduced RV circulating in
the community. Determination of RV and NoV in wastewaters
may function as a surrogate marker for their prevalence in the
society, and thus be used as a tool for monitoring vaccine efficacy.
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